TUKYSA (tucatinib) is used to treat breast cancer.
Tukysa is a cancer medicine that is used to treat breast cancer that is locally advanced or metastatic (has spread to other parts of the body) and when it is HER2-positive. This means the cancer cells produce a protein on their surface, HER2, which stimulates the growth of the cancer.
| Brand Name: | TUKYSA |
| Generic Name: | tucatinib |
| Strength: | • Tablets: 50 mg and 150 mg. |
| Manufacturer: | Seagen |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
Get access TUKYSA for breast cancer treatment through Named-Patient Import in India
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to TUKYSA (tucatinib) Tablets for personal use. For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
